Subtotal Hysterectomy May Suffice

Clinician Reviews 13(2):82, 2003. © 2003 Clinicians Group, LLC

Posted 04/09/2003

For women with benign conditions requiring hysterectomy, a subtotal procedure (ie, in which the cervix is conserved) has no more effect on pelvic organ function than does total abdominal hysterectomy. As British researchers report in a recent issue of the New England Journal of Medicine, women undergoing subtotal hysterectomy recover more quickly and experience fewer complications one year postsurgery than do women who have a total hysterectomy. Instances of cyclical bleeding and cervical prolapse may occur in subtotal-hysterectomy patients, however.

Participants in a group of 279 women, younger than 60 and most premenopausal, were randomized to undergo total or subtotal abdominal hysterectomy to treat a benign condition. Three of 146 women in the total-hysterectomy group and five of 133 women in the subtotal-hysterectomy group did not have their assigned procedure. Eighty-one total-hysterectomy patients and 61 subtotal-hysterectomy patients also underwent bilateral salpingo-oophorectomy.

Women who had total abdominal hysterectomy required longer surgeries than did women in the subtotal-hysterectomy group, as well as longer hospital stays -- perhaps because the former were more likely to develop fever and require antibiotic therapy. Low rates of minor complications were reported in both groups.

At six months and one year, Thakar and colleagues assessed bladder, bowel, and sexual function and recorded postoperative complications. Urinary frequency was reduced by similar rates in both groups -- a benefit the investigators could not explain, as it was found in women both with and without fibroids (a possible source of pressure). No significant changes were found in either group regarding constipation, laxative use, or frequency of intercourse or orgasm.

At 12 months, incidence of pelvic pain had been reduced from 8.9% to 4.8% of the total-hysterectomy patients and from 3.8% to 2.3% of subtotal-hysterectomy patients. Bowel obstructions were reported in 1.4% of total-hysterectomy patients. Among women in the subtotal-hysterectomy group, 6.8% experienced cyclical vaginal bleeding and 1.5%, cervical prolapse. "Even small amounts of endometrial tissue could result in abnormal bleeding," the study authors explained, "if hormone-replacement therapy was prescribed." They recommend formal reverse conization to minimize the likelihood of this complication. Additionally, they note, women who undergo subtotal hysterectomy will continue to need regular Papanicolaou smears.

When choosing between the two surgical procedures to treat benign disease, Thakar et al suggest that clinicians take into account patient preferences, based on projected outcomes.

Thakar R, Ayers S, Clarkson P, et al. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med. 2002;347:1318-1325.

 

 

Outcomes after Total versus Subtotal Abdominal Hysterectomy
Ranee Thakar, M.D., Susan Ayers, Ph.D., Peter Clarkson, M.D., Stuart Stanton, M.D., and Isaac Manyonda, M.D., Ph.D.

 

ABSTRACT

Background It is uncertain whether subtotal abdominal hysterectomy results in better bladder, bowel, or sexual function than total abdominal hysterectomy.

Methods We conducted a randomized, double-blind trial comparing total and subtotal abdominal hysterectomy in 279 women referred for hysterectomy because of benign disease; most of the women were premenopausal. The main outcomes were measures of bladder, bowel, and sexual function at 12 months. We also evaluated postoperative complications.

Results The rates of urinary frequency (urination more than seven times during the day) were 33 percent in the subtotal-hysterectomy group and 31 percent in the total-hysterectomy group before surgery, and they fell to 24 percent and 20 percent, respectively, at 12 months (P=0.03 for the change over time within each group; P=0.84 for the interaction between the treatment assignment and time). The reduction in nocturia and stress incontinence and the improvement in bladder capacity were similar in the two groups. The frequency of bowel symptoms (as indicated by reported constipation and use of laxatives) and measures of sexual function (including the frequency of intercourse and orgasm and the rating of the sexual relationship with a partner) did not change significantly in either group after surgery. The women in the subtotal-hysterectomy group had a shorter hospital stay (5.2 days, vs. 6.0 in the total-hysterectomy group; P=0.04) and a lower rate of fever (6 percent vs. 19 percent, P<0.001). After subtotal abdominal hysterectomy, 7 percent of women had cyclical bleeding and 2 percent had cervical prolapse.

Conclusions Neither subtotal nor total abdominal hysterectomy adversely affects pelvic organ function at 12 months. Subtotal abdominal hysterectomy results in more rapid recovery and fewer short-term complications but infrequently causes cyclical bleeding or cervical prolapse.


Hysterectomy is the most common major gynecologic operation in the United Kingdom and the United States.1,2 It is associated with higher rates of patient satisfaction than are other treatments for dysfunctional uterine bleeding.3 However, since hysterectomy disrupts the local nerve supply and anatomical relationships, it has been thought that overall pelvic organ function might be adversely affected. Total abdominal hysterectomy involves the removal of both the body of the uterus and the cervix, whereas subtotal abdominal hysterectomy conserves the cervix. Because the subtotal procedure minimizes anatomical disruption, it may be less likely to have adverse effects than total hysterectomy. The concern that cancer might develop in the cervical stump is no longer considered a justification for routine use of total abdominal hysterectomy; screening reduces the incidence of invasive cancer,4 and the risk of cervical cancer after subtotal abdominal hysterectomy is less than 0.1 percent.5 Injury to the urinary tract, which occurs in 0.5 to 3.0 percent of cases,6 is the most frequent cause of litigation after total abdominal hysterectomy.7 Subtotal abdominal hysterectomy requires less mobilization of the bladder and minimizes the risk of injury to the ureters. The subtotal procedure is also associated with lower rates of wound infection, hematoma,8 and symptomatic vault granulation.9

A recent systematic review10 of studies comparing the effects of subtotal abdominal hysterectomy and total abdominal hysterectomy on urinary function identified only three studies11,12,13 of sufficiently high methodologic quality to be included in the analysis. Two were observational studies that showed an increased risk of incontinence among women who had undergone total abdominal hysterectomy.11,12 The third13 was a small randomized, controlled trial showing no advantages of one operation over the other. Most studies of the effect of hysterectomy on bowel function14,15,16,17 have been retrospective, with small numbers of women and a lack of adequate controls; some have not defined the type or route of the hysterectomy. Although a series of nonrandomized studies12,18,19,20 showed that subtotal abdominal hysterectomy had advantages over total abdominal hysterectomy with respect to urinary and sexual function, a subsequent study from the same institution21 failed to confirm these findings.

We conducted a prospective, randomized, double-blind, multicenter study to test the hypothesis that, as compared with total abdominal hysterectomy, subtotal abdominal hysterectomy results in better urinary, bowel, and sexual function, more rapid recovery, and a reduced rate of complications.

Methods

Subjects

We recruited women who had been offered abdominal hysterectomy for a benign indication at two London hospitals between January 1996 and April 2000. Exclusion criteria were an age over 60 years, suspected cancer, a body weight that exceeded 100 kg, previous pelvic surgery, known endometriosis, abnormal cervical smears, symptomatic uterine prolapse, and symptomatic urinary incontinence for which the patient might seek expert medical advice. All women provided written informed consent. The research ethics committee at each participating hospital approved the study.

Study Design

The women were randomly assigned to the treatment groups with the use of computer-generated numbers. The sealed opaque envelope containing the assignment was opened only after the surgical incision had been made. The women and the investigator who evaluated the outcomes were unaware of treatment assignments throughout the 12-month study period. Each operation was carried out or supervised by an experienced surgeon, with the use of the clamp-cut-ligate method,22 polyglycolic sutures, and antibiotic prophylaxis. The endocervical canal was electrocoagulated during subtotal abdominal hysterectomy. Bilateral salpingo-oophorectomy, the only concomitant procedure, was performed at the surgeon's discretion or at the patient's request.

Data were collected on the duration of the operation (from incision of the skin to closure), estimated blood loss, the length of the hospital stay, postoperative hemoglobin values, pain scores on days 2 and 4, blood transfusion, and intraoperative, early, and late complications.

Assessment of Urinary, Bowel, and Sexual Function

Urinary, bowel, and sexual function was evaluated before surgery and 6 and 12 months afterward. Urinary function was determined with the use of twin-channel subtracted cystometrography and uroflowmetry, as well as the women's responses to a subjective standardized questionnaire used by the Urogynecology Unit at St. George's Hospital. Definitions of urinary incontinence conformed to those of the International Continence Society.23 Bowel function was evaluated on the basis of responses to a previously validated questionnaire.17

Sexual function was evaluated with a questionnaire that had been used in a pilot study. Internal reliability in the sample of sexually active women was reasonable (Cronbach's alpha, 0.68). We restricted the analyses of sexual function to women who were sexually active at all three time points. There were no significant differences in the proportions of women in each group who were sexually active at each time point.

Statistical Analysis

On the basis of a previous randomized, controlled study in which 55 percent of women had stress incontinence after abdominal hysterectomy,24 we determined that we would need to enroll 138 women in each treatment group in order to detect an 18 percent difference between the groups with 90 percent power at an alpha level of 0.05.

Data were analyzed with the use of SPSS software (version 9). Repeated-measures analysis of variance was performed to determine the main effect of the type of operation, regardless of the time point, and the main effect of time, regardless of the type of operation, and to determine whether there was an interaction between the type of operation and time. Extremely skewed variables that could not be corrected by transformations were made dichotomous and analyzed with the use of linear models for categorical data.25 Student's paired t-tests were used for normally distributed data, and the chi-square test was used for categorical data. The effects of covariates (age, presence or absence of fibroids, use or nonuse of hormone-replacement therapy, and performance or nonperformance of bilateral salpingo-oophorectomy) on urinary, bowel, and sexual function were examined with the tests indicated above.

Results

The two treatment groups were similar in age, weight, parity, menopausal status, race or ethnic group, and indication for hysterectomy, with the exception that menorrhagia alone as an indication was more frequent in the subtotal-hysterectomy group than in the total-hysterectomy group. Of the 146 women randomly assigned to the total-hysterectomy group, 3 did not undergo the procedure, because of a frozen pelvis (i.e., dense pelvic adhesions, completely distorting the normal anatomy) in 1, an adherent bladder in another, and an adherent bladder and bowel in the third. Of the 133 women randomly assigned to the subtotal-hysterectomy group, 5 did not undergo the procedure. For three of the five women, the reasons were a bleeding cervical stump, bilateral ovarian cysts, and inadvertent entry into the vagina; no reason was given for the other two. Bilateral salpingo-oophorectomy was performed in 81 of the women who underwent total abdominal hysterectomy and in 61 of those who underwent subtotal abdominal hysterectomy. Follow-up data were unavailable for 14 women at 6 months and for 21 women at 12 months in the total-hysterectomy group and for 12 and 11 women, respectively, in the subtotal-hysterectomy group. Analyses were based only on data that were available at both 6 and 12 months. There were no significant differences in base-line characteristics between the group of women for whom follow-up data were available at 6 and 12 months and the group of women for whom complete follow-up data were not available.


Complications

Total abdominal hysterectomy was associated with a significantly longer duration of surgery, greater blood loss, and a longer hospital stay than was subtotal abdominal hysterectomy. No visceral damage was sustained in either group. Pyrexia was more frequent after total abdominal hysterectomy, as was antibiotic use. Some minor complications, such as retention of urine and vault hematoma, occurred only in the total-hysterectomy group (in two women and in one woman, respectively). The rates of wound infection and wound hematoma were similar in the two groups.

 
At 12 months, nine women in the subtotal-hysterectomy group (6.8 percent) had cyclical vaginal bleeding, two (1.5 percent) had cervical prolapse (i.e., the cervix protruded outside the introitus), and three (2.3 percent) had persistent pelvic pain. Seven women in the total-hysterectomy group had persistent pelvic pain (4.8 percent), and two had bowel obstruction (1.4 percent), one at four weeks and the other at four months. None of the women with pelvic pain had endometriosis.

Bladder and Bowel Function

The preoperative and postoperative rates of urinary frequency (defined as urination more than seven times during the day), stress incontinence, urgency, urge incontinence, poor stream, interrupted stream, and incomplete bladder emptying did not differ significantly between the two groups . Smaller proportions of women in the subtotal-hysterectomy group had dysuria, straining to void, and nocturia postoperatively, but these differences predated surgery. In both groups significantly fewer women had stress incontinence, urgency, urinary frequency, nocturia, interrupted stream, and incomplete emptying over time. Follow-up rates for urodynamic studies were lower than anticipated because some women declined the tests at 6 and 12 months, although they agreed to participate in the other assessments. After surgery, the volume of urine voided when the urge to micturate was first experienced, the volume of urine voided when a strong urge to micturate was experienced, and the maximal capacity (the largest volume of urine held) increased in both groups, whereas the peak flow rate did not change significantly. Urodynamic studies showed a reduction in stress incontinence after surgery in both groups.


We also looked at changes in urinary function after surgery according to the presence or absence of fibroids preoperatively, since fibroids are often associated with urinary symptoms. Approximately 10 percent of women without fibroids, as compared with 17 percent of those with fibroids, reported micturition more than seven times a day preoperatively. The rate remained similar after surgery among the women without fibroids but fell to 9 percent six months after surgery among those with fibroids (P=0.003 for the interaction between the presence or absence of fibroids and time). Among the women with fibroids, the reduction in urinary frequency was similar in the two treatment groups (data not shown). Improvements in other measures of urinary function were not associated with the presence or absence of fibroids (data not shown).

The rates of constipation, hard stools, urgency, straining, use of laxatives, and incontinence of flatus were similar in the two treatment groups after surgery.


Sexual Function

Before surgery, 112 women in the subtotal-hysterectomy group (84 percent) and 122 in the total-hysterectomy group (84 percent) were sexually active; the corresponding figures were 95 (71 percent) and 106 (73 percent) at 6 months and 100 (75 percent) and 96 (66 percent) at 12 months. Reasons for celibacy included lack of a partner, divorce or separation, and concurrent illness. In the total-hysterectomy group, no previously celibate woman became sexually active after surgery, whereas in the subtotal-hysterectomy group, one woman became sexually active at 6 months and another at 12 months. Because the multivariate analyses we used required data at all time points, the analyses were limited to the 91 women in the subtotal-hysterectomy group and the 86 women in the total-hysterectomy group who were sexually active at all three points in time.

The frequency of intercourse, desire for intercourse, and initiation of intercourse did not differ significantly between the two groups before surgery or 6 or 12 months afterward (data not shown). However, there was a significant increase in the frequency of intercourse in both groups combined after surgery (P=0.01), with no significant effect of the type of surgery on this outcome. The two groups were similar postoperatively with respect to the frequency of orgasm, frequency of multiple orgasm, extent of vaginal lubrication, and rating of the sexual relationship with a partner. Deep dyspareunia was reduced significantly in both groups at 6 and 12 months, whereas superficial dyspareunia decreased at 6 months but increased at 12 months.


Discussion

In this prospective, randomized, double-blind, multicenter trial, urinary, bowel, and sexual function at one year was similar in the group of women who had undergone total abdominal hysterectomy and in those who had undergone subtotal abdominal hysterectomy. Neither procedure had apparent adverse effects on these functions; indeed, some measures of urinary function improved, and the rate of deep dyspareunia decreased. We used outcome measures that have been validated for accuracy and reproducibility. A variety of surgeons performed the operations, suggesting that the results are widely applicable. The investigator who evaluated outcomes and the patients were unaware of the treatment assignments. Recognizing that the effect of surgery on pelvic organ function may evolve over time, we followed patients for at least 12 months.

With total abdominal hysterectomy, much of the operative time, cost, and morbidity are associated with the removal of the cervix.26 We found that subtotal abdominal hysterectomy required less operative time and was associated with less blood loss. Other investigators have reported a higher incidence of abscesses and wound infection after total abdominal hysterectomy,8 which is often attributed to contamination of the abdominal cavity by vaginal flora during the procedure. In our study, there was a significantly higher incidence of pyrexia and use of antibiotics in the total-hysterectomy group, which may have contributed to the longer hospital stay in this group. Despite endocervical cautery, 6.8 percent of women reported cyclical bleeding after subtotal abdominal hysterectomy. This finding is potentially important, since most women would expect to stop menstruating after a hysterectomy. We speculate that formal reverse conization, whereby the cervical epithelium, including the transformation zone, along with any residual endometrium, is excised through the abdominal wound, might minimize this complication. Even small amounts of endometrial tissue could result in abnormal bleeding if hormone-replacement therapy was prescribed. Cervical prolapse occurred in two women in the subtotal-hysterectomy group but in none of those in the total-hysterectomy group. However, it might be too early to draw firm conclusions on the basis of this finding, since the frequency of prolapse may increase over time.

Our finding that some measures of urinary function improved with either type of surgery corroborates a previous report by Virtanen et al.21 Langer et al.27 attributed similar findings to the removal of fibroids, but with the exception of urinary frequency, we found improvements whether or not fibroids had been removed. Urodynamic measures of bladder capacity did not differ significantly between our two groups, but in both groups there was a significant increase over time in these measures. This effect could not be attributed to elimination of the pressure effects of fibroids, since the findings were similar in the women with fibroids and in those without fibroids. There was also a reduction in the number of asymptomatic women who had stress incontinence on the basis of urodynamic studies. Similar findings have been reported,28 although postoperative deterioration in symptoms and urodynamic measures has also been described.29 The mechanism for the improvement we observed is not clear.

Women often date the onset of bowel symptoms to previous gynecologic surgery. However, bowel dysfunction is common among women with gynecologic symptoms,15,30,31,32 even in the absence of surgery. We found no difference in any of the measures of bowel function between the two groups before or after surgery or over time. Our findings are consistent with the results of a nonrandomized study in which 42 women were evaluated before and 18 months after they underwent subtotal or total abdominal hysterectomy.33

A few studies have suggested that hysterectomy adversely affects sexuality.34,35 Our findings corroborate the results of the majority of studies, which have found no adverse effects.36,37,38 We found no differences between the two operations with regard to subsequent frequency of intercourse, sexual desire, frequency of initiating intercourse, or orgasm; there was a reduction in deep dyspareunia in both treatment groups. We cannot explain the reduction in superficial dyspareunia at six months and the increase at one year, especially since there was no change in vaginal lubrication. We cannot exclude the possibility that hysterectomy has an effect on subtle, qualitative aspects of sexual function that we did not measure.

Although it seems biologically plausible that the disruption of local innervation and anatomical relationships caused by hysterectomy might lead to organ dysfunction, our findings, as well as the consistently high satisfaction rates reported in other studies in association with simple hysterectomy,3,39,40,41,42 suggest that substantial pelvic organ dysfunction is uncommon after total or subtotal abdominal hysterectomy. A recent study by Butler-Manuel et al.43 suggests a possible explanation. These investigators showed that the uterosacral and cardinal ligaments had a significantly greater autonomic-nerve content in the middle-to-lateral third of the ligaments than in the medial third (where these ligaments enter the uterine body and cervix). During simple hysterectomy, only the ligaments with nerves innervating the uterus and cervix are interrupted, sparing those innervating the surrounding structures. In contrast, radical hysterectomy, in which the ligaments are divided more laterally, has been associated with greater disturbance of pelvic organ function.44

In conclusion, our data provide reassurance that neither total nor subtotal abdominal hysterectomy adversely affects pelvic organ function. Subtotal abdominal hysterectomy is easier to perform than total abdominal hysterectomy, with less risk of ureteric damage, but requires that women have regular Pap smears and results in cyclical bleeding in a minority of women. Consideration of patients' preferences based on expected outcomes might further improve satisfaction rates after hysterectomy performed because of a benign condition.45

 

Supported by a grant (SPGS 202) from the Responsive Funding Programme, Research and Development, National Health Service Executive, London (to Dr. Manyonda).

The views expressed in this article are those of the authors and not necessarily those of the National Health Service Executive or the Department of Health.

We are indebted to Austin Ugwumadu for sealing the randomization envelopes, to our colleagues who generously allowed us to recruit their patients for the study, and especially to all the women who graciously consented to participate.


Source Information

From the Department of Gynecology, St. George's Hospital, London (R.T., S.S., I.M.); the Department of Psychology, St. George's Hospital Medical School, London (S.A.); and the Department of Obstetrics and Gynecology, Mayday University Hospital, Croydon, United Kingdom (P.C.).

Address reprint requests to Dr. Manyonda at the Department of Obstetrics and Gynecology, St. George's Hospital, Blackshaw Rd., London SW17 0QT, United Kingdom, or at imanyond@sghms.ac.uk.

References

 

  1. Department of Health. Hospital episode statistics. London: Elephant & Castle, 1998-1999.
  2. Lepine LA, Hillis SD, Marchbanks PA, et al. Hysterectomy surveillance -- United States, 1980-1993. Mor Mortal Wkly Rep CDC Surveill Summ 1997;46:1-14.
  3. Dwyer N, Hutton J, Stirrat GM. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for surgical treatment of menorrhagia. Br J Obstet Gynaecol 1993;100:237-243. [ISI][Medline]
  4. Herbert A. Cervical screening in England and Wales: its effect has been underestimated. Cytopathology 2000;11:471-479. [CrossRef][ISI][Medline]
  5. Kilkku P, Grönroos M. Peroperative electrocoagulation of endocervical mucosa and later carcinoma of the cervical stump. Acta Obstet Gynecol Scand 1982;61:265-267. [ISI][Medline]
  6. Hendry WF. Urinary tract injuries during gynaecological surgery. In: Studd J, ed. Progress in obstetrics and gynaecology. Vol. 5. Edinburgh, Scotland: Churchill Livingstone, 1985:362-77.
  7. Whitelaw JM. Hysterectomy: a medical-legal perspective, 1975 to 1985. Am J Obstet Gynecol 1990;162:1451-1458. [ISI][Medline]
  8. Nathorst-Boos J, Fuchs T, von Schoultz B. Consumer's attitude to hysterectomy: the experience of 678 women. Acta Obstet Gynecol Scand 1992;71:230-234. [ISI][Medline]
  9. Manyonda IT, Welch CR, McWhinney NA, Ross LD. The influence of suture material on vaginal vault granulations following abdominal hysterectomy. Br J Obstet Gynaecol 1990;97:608-612. [ISI][Medline]
  10. Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet 2000;356:535-539. [CrossRef][ISI][Medline]
  11. Iosif CS, Bekassy Z, Rydhstrom H. Prevalence of urinary incontinence in middle-aged women. Int J Gynaecol Obstet 1988;26:255-259. [ISI][Medline]
  12. Kilkku P. Supravaginal uterine amputation versus hysterectomy with reference to subjective bladder symptoms and incontinence. Acta Obstet Gynecol Scand 1985;64:375-379. [ISI][Medline]
  13. Lalos O, Bjerle P. Bladder wall mechanics and micturition before and after subtotal and total hysterectomy. Eur J Obstet Gynecol Reprod Biol 1986;21:143-150. [ISI][Medline]
  14. Taylor T, Smith AN, Fulton PM. Effect of hysterectomy on bowel function. BMJ 1989;299:300-301. [ISI][Medline]
  15. Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: `idiopathic slow transit constipation.' Gut 1986;27:41-48. [Abstract]
  16. Prior A, Stanley K, Smith ARB, Read NW. Effect of hysterectomy on anorectal and urethrovesical physiology. Gut 1992;33:264-267. [Abstract]
  17. Heaton KW, Parker D, Cripps H. Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy -- a population based study. Gut 1993;34:1108-1111. [Abstract]
  18. Kilkku P, Hirvonen T, Gronroos M. Supra-vaginal uterine amputation vs. abdominal hysterectomy: the effects on urinary symptoms with special reference to pollakisuria, nocturia and dysuria. Maturitas 1981;3:197-204. [ISI][Medline]
  19. Kilkku P, Gronroos M, Hirvonen T, Rauramo L. Supravaginal uterine amputations vs. hysterectomy: effects on libido and orgasm. Acta Obstet Gynecol Scand 1983;62:147-152. [ISI][Medline]
  20. Kilkku P. Supravaginal uterine amputation vs. hysterectomy: effects on coital frequency and dyspareunia. Acta Obstet Gynecol Scand 1983;62:141-145. [ISI][Medline]
  21. Virtanen HS, Makinen JI, Tenho T, Kiiholma P, Pitkanen Y, Hirvonen T. Effects of abdominal hysterectomy on urinary and sexual symptoms. Br J Urol 1993;72:868-872. [ISI][Medline]
  22. Abdominal hysterectomy for benign conditions. In: Hawkins J, Hudson CN, eds. Shaw's textbook of operative gynaecology. 4th ed. Edinburgh, Scotland: Churchill Livingstone, 1977:146-75.
  23. Abrams P, Blaivas JG, Stanton SL, Anderson JT. The standardisation of terminology of lower urinary tract function. Scand J Urol Nephrol Suppl 1988;114:5-19. [Medline]
  24. Bhattacharya S, Mollison J, Pinion S, et al. A comparison of bladder and ovarian function two years following hysterectomy or endometrial ablation. Br J Obstet Gynaecol 1996;103:898-903. [Erratum, Br J Obstet Gynaecol 1996;103:1273.] [ISI][Medline]
  25. Guthrie D. Analysis of dichotomous variables in repeated measures experiments. Psychol Bull 1981;90:189-195. [CrossRef][ISI]
  26. Munro MG, Deprest J. Laparoscopic hysterectomy: does it work? A bicontinental review of the literature and clinical commentary. Clin Obstet Gynecol 1995;38:401-425. [ISI][Medline]
  27. Langer R, Golan A, Neuman M, Schneider D, Bukovsky I, Caspi E. The effect of large uterine fibroids on urinary bladder function and symptoms. Am J Obstet Gynecol 1990;163:1139-1141. [ISI][Medline]
  28. Kujansuu E, Teisala K, Punnonen R. Urethral closure function after total and subtotal hysterectomy measured by urethrocystometry. Gynecol Obstet Invest 1989;27:105-106. [ISI][Medline]
  29. Parys BT, Haylen BT, Hutton JL, Parsons KF. The effects of simple hysterectomy on vesicourethral function. Br J Urol 1989;64:594-599. [ISI][Medline]
  30. Prior A, Whorwell PJ. Gynaecological consultation in patients with the irritable bowel syndrome. Gut 1989;30:996-998. [Abstract]
  31. Longstreth GF, Preskill DB, Youkeles L. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy: relation to gynecologic features and outcome. Dig Dis Sci 1990;35:1285-1290. [ISI][Medline]
  32. Hogston P. Irritable bowel syndrome as a cause of chronic pain in women attending a gynaecology clinic. Br Med J (Clin Res Ed) 1987;294:934-935. [ISI][Medline]
  33. Goffeng AR, Andersch B, Antov S, Berndtsson I, Oresland T, Hulten L. Does simple hysterectomy alter bowel function? Ann Chir Gynaecol 1997;86:298-303. [ISI][Medline]
  34. Dennerstein L, Wood C, Burrows GD. Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 1977;49:92-96. [ISI][Medline]
  35. Poad D, Arnold EP. Sexual function after pelvic surgery in women. Aust N Z J Obstet Gynaecol 1994;34:471-474. [ISI][Medline]
  36. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999;282:1934-1941. [Abstract/Full Text]
  37. Helström L, Lundberg PO, Sörborm D, Bäckström T. Sexuality after hysterectomy: a factor analysis of women's sexual lives before and after subtotal hysterectomy. Obstet Gynecol 1993;81:357-362. [ISI][Medline]
  38. Coppen A, Bishop M, Beard RJ, Barnard GJ, Collins WP. Hysterectomy, hormones, and behaviour: a prospective study. Lancet 1981;1:126-128. [ISI][Medline]
  39. Gannon MJ, Holt EM, Fairbank J, et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ 1991;303:1362-1364. [ISI][Medline]
  40. Pinion SB, Parkin DE, Abramovich DR, et al. Randomised trial of hysterectomy, endometrial laser ablation and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ 1994;309:979-983. [Abstract/Full Text]
  41. Weber AM, Walters MD, Schover LR, Church JM, Piedmonte MR. Functional outcomes and satisfaction after abdominal hysterectomy. Am J Obstet Gynecol 1999;181:530-535. [ISI][Medline]
  42. Kjerulff KH, Langenberg PW, Rhodes JC, Harvey LA, Guzinski GM, Stolley PD. Effectiveness of hysterectomy. Obstet Gynecol 2000;95:319-326. [CrossRef][ISI][Medline]
  43. Butler-Manuel SA, Buttery LDK, A'Hern RP, Polak JM, Barton DPJ. Pelvic nerve plexus trauma at radical hysterectomy and simple hysterectomy: the nerve content of the uterine supporting ligaments. Cancer 2000;89:834-841. [Erratum, Cancer 2000;89:2144.] [CrossRef][ISI][Medline]
  44. Butler-Manuel SA, Summerville K, Ford AM, et al. Self assessment of morbidity following radical hysterectomy for cervical cancer. Br J Obstet Gynaecol 1999;19:180-183. [CrossRef]
  45. Drife JO. Conserving the cervix at hysterectomy. Br J Obstet Gynaecol 1994;101:563-564. [ISI][Medline]

 

Supracervical hysterectomy: Back to the future?

D. E. Darnell Jones, MD 
D. Paul Shackelford, MD 
Robert G. Brame, MD 
Greenville and Charlotte, North Carolina

   Abstract  TOP 

Supracervical hysterectomy, commonly performed in the earlier decades of this century, is rarely performed in contemporary practice. The desire to prevent future cervical cancer initially underlay the advocacy of total hysterectomy. Cervical cytologic screening and effective outpatient treatment of preinvasive cervical disease are commonly available. Cancer of the cervical stump is an uncommon and largely preventable occurrence. Removal of the normal cervix reportedly may have adverse effects on bladder, bowel, and sexual function. Reduced operating time and a shorter recovery period may be associated with a supracervical procedure. The risk of subsequent cervical cancer may not outweigh the benefits of supracervical hysterectomy, which should be offered as an option to selected patients. Supracervical hysterectomy by minilaparotomy is within the capability of practicing gynecologists and may be adaptable to outpatient short-stay surgery, offering a cost-effective alternative for a variety of gynecologic conditions. (Am J Obstet Gynecol 1999;180:513-5.)

 

Over the years some of the cherished tools of our trade have been removed from the clinical arena and have become decorative memorabilia adorning our bookshelves. The Thoms’ pelvimeter nestles quietly beside the Barton forceps. Over the years long-held tenets of care have come to rest on their own virtual bookshelves. Sodium restriction, strict control of weight gain in pregnancy, and prophylactic diuretics surely seemed the right way to prevent preeclampsia once upon a time. We embrace technologic innovations easily, at times even before their demonstrated value. Clinical opinions and dogma are tenacious and change only when well-designed studies provide incontrovertible evidence and then only slowly.

In the earlier decades of this century the mortality associated with total abdominal hysterectomy was at least double that associated with a supracervical procedure. During that era almost all hysterectomies performed in the United States were supracervical. Total hysterectomy was reserved for patients in whom removal of the cervix was essential for management of disease. By the middle of the century advances in anesthetic agents, improved anaesthetic and surgical techniques, the development of blood transfusions, and the discovery of antibiotics significantly reduced operative mortality and morbidity. However, cervical cancer was an occult disease until it became grossly invasive. Surgical or radiation therapy was associated with significant complications and did not result in the survival rates we currently experience. Removal of the cervix with the uterus then became the preferred mode of practice with little scientific rationale supporting this change other than an anticipated reduction in cervical malignancies. Certainly, the ability to perform a total hysterectomy set us apart from the general surgeons who, during the infancy of our specialty, performed a significant amount of female pelvic surgery. There is no doubt that the exclusivity of this approach enhanced its value in the eyes of the gynaecologists. There is some persistence in the belief that “real gynaecologists” always remove the cervix. Routine removal of the normal cervix with the uterus continues to rest almost entirely on the premise that elective cervicectomy with hysterectomy is appropriate for prophylaxis against subsequent cervical cancer.

After the introduction of cytological screening, newer technologies permitted effective identification and treatment of preinvasive cervical cancer in the ambulatory setting. Dysplastic lesions are frequently treated with the same vigor that our predecessors showed when they approached invasive disease, thereby reducing the incidence of cervical cancer. Invasive disease is largely confined to the unscreened population. Rapid progression to invasion is commonly seen only in severely immunocompromised patients and those rare patients with poorly differentiated small-cell tumours.

Is the risk of subsequent cervical cancer a valid reason for routine total abdominal hysterectomy in contemporary practice? Carcinoma of the cervical stump and carcinoma of the vagina are currently rare diseases with an incidence in the range of 1 per 1000 to 1½ per 1000. The incidence of vaginal carcinoma is the greater of the two; however, we have yet to hear the argument that vaginectomy should be performed routinely to avoid this risk. The cervix appears to be perceived by some as having no useful function, and therefore its routine removal with the uterus should have no long-term disadvantages.

However, there are many aphorisms that can be used to argue in favour of leaving the normal cervix in situ at the time of abdominal hysterectomy. We treat endometrial disease by ablative procedures but leave the “useless” cervix in place. Why do we feel obliged to remove it routinely if we treat the same condition by hysterectomy? In developed countries it is easy to detect and treat preinvasive disease of the cervix and the cervical stump and thereby prevent invasive disease. Arguments by even the most ardent proponents of routine cervicectomy that the number of subsequent Papanicolaou smears is reduced appear specious at best. Posthysterectomy vaginal cancer itself may warrant cytological screening regardless of the presence or absence of the cervix if identification of rare disorders is desirable. In some patients, most notably, those with either morbid obesity, severe pelvic infection, or adhesive disease, removing the cervix is associated with a greatly increased risk of unintended injury to other organs. There may be no scientific studies to support this assertion, but it is so self-evident to any gynaecologic surgeon that it should need no further proof. Intraoperative complications are, at least in theory, more possible, if not more likely, in all patients. Supracervical hysterectomy, by any logic, should result in less operative time, less soft tissue dissection, and therefore less risk of operative misadventures. Less a self-evident truth but nonetheless a valid proposition is the belief that avoiding vaginal entry will result in less infectious morbidity. Time-honoured science dictates that contaminating a clean operative field with a dirty one is not wise, prophylactic antibiotics notwithstanding.

Recent articles by Munro1 and Johns2 have reviewed and provided contemporary references to published studies related to the possible advantages and disadvantages of total and supracervical hysterectomy. The current literature raises valid questions regarding bladder, bowel, and sexual dysfunction after removal of the cervix. Concerns about the loss of pelvic support after cervicectomy and issues related to operating time and intraoperative and postoperative complications have been presented. At present, there appear to be no definitive data concerning the effects of hysterectomy, with or without removal of the cervix, on bowel, bladder, and sexual function or symptoms. Prospective or even retrospective studies sufficient to resolve the issues of postoperative vault prolapse, infectious morbidity, and intraoperative complications remain unpublished. Sexual dysfunction is a complex issue and is not readily amenable to definitive scientific evaluation. Convincing data are currently not available and in all likelihood will remain elusive.

In the absence of clear imperatives to perform total hysterectomy, of interest is the possibility that improvements in surgical and perioperative techniques may permit supracervical hysterectomy to become an appropriate outpatient surgical management option in a variety of gynaecologic problems. We currently perform vaginal hysterectomy and major adnexal abdominal surgery in an outpatient short-stay facility. Whereas laparoscopic supracervical procedures have been described, a more cost-effective supracervical hysterectomy accomplished by innovative modifications of current mini-laparotomy techniques should be considered. This procedure, which may be performed easily by all practicing gynaecologists because it does not require laparoscopic expertise, may well be feasible in the ambulatory surgical facility. Endometrial ablation still falls short of providing the desired “endometrectomy” for dysfunctional bleeding. Given the alternatives of low morbidity and cost-effective supracervical hysterectomy or tubal sterilization, some women may welcome a more effective sterilization procedure that relieves them of chronic dysmenorrhoea, provides a lifestyle unencumbered by menses, provides superior prophylaxis against subsequent endometrial carcinoma, and permits oestrogen replacement without the addition of antagonistic and at times unacceptable progestin therapy.

Supracervical hysterectomy has long been considered appropriate if intraoperative complications dictate completing the essential surgery as rapidly as possible. In practice, this option has rarely been selected. Currently, in our practice supracervical hysterectomy is being planned more frequently in patients with higher than average risks for perioperative complications. We believe that the advantages of a shorter operative time, less soft tissue dissection, less potential for collateral organ injury, and a potential reduction in infectious morbidity must be considered. We are becoming increasingly more comfortable in leaving the cervix in situ in a variety of circumstances. We also perform a total hysterectomy in healthy patients in whom the potentially increased risks and consequences of removing the cervix seem, in our best “clinical judgment,” to be inconsequential. Some members of our academic group practices are more firmly rooted in the total hysterectomy camp than others, reflecting the current lack of consensus in our discipline.

In the future, if well-designed studies demonstrate a clear superiority of supracervical hysterectomy, we should retire the routine total hysterectomy to its own virtual bookshelf and remove the cervix only if necessary to treat disease. The small risk of subsequent cervical carcinoma in these circumstances would not appear to justify removal of an uninvolved cervix, which may be only an “innocent bystander.”

At present, however, there is no scientific method by which we can weigh absolutely the benefits of supracervical versus total abdominal hysterectomy that will permit the application of either method as the sine qua non of gynaecologic practice. But if the cervix does indeed have a sexual function and if, as anatomists would have us believe, motor and sensory bladder innervation is at the least more modified by cervical removal than by conservation and if pelvic support is at least as good, if not better, as some of us believe, with supracervical hysterectomy, then that operation needs to be included in the options available to patients who have no cervical abnormalities.

It seems incumbent on those who reject supracervical hysterectomy to provide data which suggest more strongly than what we now know that it is an unacceptable alternative. Currently, those studies which show that one choice is better than the other seem many years away and in fact may never be forthcoming. When we incorporate what we know about anatomy and physiology and what years of surgical experience tell us, however, it is both logical and appropriate that supracervical hysterectomy be included in our armamentarium once more. The uncomfortable feelings experienced by many gynaecologic surgeons contemplating less than a total hysterectomy need to be assuaged.

   REFERENCES  TOP